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Abstract
Background: Prior research has explored spatial access to syringe exchange programs (SEPs) among people who
inject drugs (PWID), but little is known about service utilization by former PWID who continue to access services
(e.g., HIV screenings and referrals for social services) at harm reduction providers. The purpose of this research is to
examine differences in access to SEPs between current and former PWID seeking services at a mobile SEP in
Washington, DC.
Findings: A geometric point distance estimation technique was applied to data collected as part of a PWID population
estimation study that took place in Washington, DC, in March and April 2014. We calculated the walking distance from
the centroid point of home residence zip code to the mobile exchange site where PWID presented for services. An
independent samples t-test was used to examine differences in walking distance measures between current and
former PWID. Differences in mean walking distance were statistically significant with current and former PWID having
mean walking distances of 2.75 and 1.80 miles, respectively.
Conclusions: The results of this study suggest that former PWID who are engaging with SEPs primarily for non-needle
exchange services (e.g., medical or social services) may have decreased access to SEPs than their counterparts who are
active injectors. This research provides support for expanding SEP operations such that both active and former PWID
have increased access to harm reduction providers and associated health and social services. Increasing service
accessibility may help resolve unmet needs among current and former PWID.
Keywords: Syringe exchange programs, Access, People who inject drugs, Harm reduction

Background
Existing research has empirically demonstrated the public health utility of syringe exchange programs (SEPs) for
people who inject drugs (PWID). These programs are
cost-effective, decrease the incidence of HIV among injectors, and have not been shown to increase drug use,
crime, or presence of discarded syringes in neighborhoods [1-5]. While engaging with SEPs, PWID may experience benefits beyond provision of sterile injection
equipment; for example, SEPs in the District of Columbia
(DC) offer referrals to other services/programs (e.g., substance use treatment programs) and provide basic medical
services (wound care, HIV/HCV screenings, etc.). For
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SEPs to be most efficacious, PWID must have easy access
to their services. Research has shown that PWID who reside in close proximity to SEPs are more likely to consistently access services [6] and are less likely to share
injection equipment [7].
Although research has quantified the distances between SEPs and areas of relevance to PWID (such as
where substances are purchased/used and home residence) [8], these findings were based on data from
2002–2006 and may not be representative of current
SEP access measures. It is plausible that SEP access
changes overtime due to organizational closures, shifts
in funding, or policy restrictions that limit SEP operations. SEP access may also vary by city.
For former PWID, it is important to maintain linkage
with SEPs in order to access non-injection-related social
and health services (e.g., referrals to housing or medical
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services) that may facilitate maintenance of sobriety
and/or safer substance use practices if relapse occurs.
No research has explored SEP access among PWID who
are not actively injecting but who continue to utilize
such services. This is an important gap in the literature
given the likelihood of relapse among PWID and the
need to maintain connections to health care resources
[9]. The purpose of this research is to extend our knowledge of SEP access for PWID via two primary aims: (1)
to provide updated estimates of distances that active injectors travel to access SEPs and (2) to quantify SEP access among former PWID who engage with SEPs for
non-needle exchange services. We hypothesized that
PWID in periods of non-active substance use would report shorter travel distances than their active injecting
counterparts.

Findings
Methods

Data from a PWID population estimation study that
used capture-recapture methodologies were used for this
research. The population estimation study was divided
into two 14-day periods of data collection with the first
phase focused on collecting data among PWID who presented for services at SEP mobile distribution sites and
the second phase focused on collecting data from PWID
sampled from community venues (such as parks or other
locations where PWID congregate). This study was conducted between March and April 2014 in partnership
with two harm reduction service providers in DC. Only
data from the largest mobile exchange program were
used in this research as this site provides the bulk of syringes to DC PWID. Further, only data from the first
phase of the population estimation study were used for
this research, as this first phase of data collection sampled PWID who traveled to SEP sites to access services.
During the population estimation study, all individuals
who presented for services received a verbal description
of the study and were given the chance to ask questions
about participation. If they verbally consented to participate, they were asked to complete an anonymous onepage survey that assessed individuals’ demographic characteristics, zip code of home residence, current frequency of substance use, methods of obtaining clean
injection equipment, and drug use preferences. Small tokens of appreciation (such as toiletries kits or new socks)
were given to each individual for their time in completing the survey. In efforts to maintain the anonymity of
individuals presenting for services, the survey did not
collect any personally identifying information.
Survey data were entered into an Access database by
two members of the research team and a 10% random
sample of surveys was checked for validation purposes.
The locations of mobile exchange sites (public parks,
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intersections, shopping center parking lots, etc.) were
geocoded using Google Maps [10]. Map data of zip
codes in the United States were downloaded from the
United States Census Bureau [11] and imported to
ArcMap v10.2.1. ArcMap was used to calculate the
latitude and longitude coordinates of the centroid
point of each zip code. Centroid point data allowed for
use of a geometric point distance estimation methodology to calculate walking distances between the centroid point of reported zip codes of home residence
and exchange site. The geometric point distance estimation method is an analytic strategy in which one assumes that the centroid point of a given unit serves as
the common origin for all data reporting that specific
unit [12,13]. In this case, the unit refers to a zip code.
A SAS macro was created that quantified the walking
distance between the two locations. Any instances where
a person reported residing in a zip code outside of DC
(thus indicating a non-DC resident) or at a post office
box zip code (which may represent a location of convenience rather than a space near the participant’s
home) were excluded from the analysis. Surveys with incomplete/missing information pertaining to substance
use behaviors and zip code of home residence were also
excluded from analysis. An independent samples t-test
was used to determine if statistically significant differences existed in walking distance measures between persons who reported active substance use and those who
reported no active substance use in the past 30 days at
the time of engagement with the SEP.
This study was reviewed and approved by The George
Washington University Institutional Review Board (IRB#
071315).

Results
During the first phase of the population estimation
study, 201 persons completed study forms. Among
these, 152 reported residing in a valid geographic residential zip code in the District of Columbia. Fifteen
forms were excluded due to missing information pertaining to injection drug use behaviors, resulting in a
final sample of 137 PWID.
Overall, the majority (71%) of participants identified as
male, African-American (78%), and with a mean age of
46.8 years. The independent samples t-test showed that
the difference in mean walking distance between active
and former PWID was statistically significant (p < .05),
with active PWID having a mean walking distance of 2.75
miles and former PWID having a mean walking distance
of 1.80 miles. These data are summarized in Table 1.
Conclusions
The results of this research show that PWID who are active and non-active injectors do not have equivalent
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Table 1 Data summary
Age (years)
Gender

Race

Walking distance (miles)*

Overall (n = 137)

Active injectors (n = 97)

Non-active injectors (n = 40)

46.8 (SD = 13.5)

47.4 (SD = 13.9)

45.6 (SD = 12.5)

Male

71% (n = 97)

68% (n = 66)

78% (n = 31)

Female

25% (n = 34)

27% (n = 26)

20% (n = 8)

Transgender

4% (n = 6)

5% (n = 5)

3% (n = 1)

Missing

0% (n = 0)

0% (n = 0)

0% (n = 0)

White/Caucasian

4% (n = 5)

5% (n = 5)

0% (n = 0)

African-American/Black

78% (n = 107)

78% (n = 76)

78% (n = 31)

Other

2% (n = 3)

0% (n = 0)

8% (n = 3)

Missing

16% (n = 22)

16% (n = 16)

15% (n = 6)

2.47 (SD = 2.10)

2.75 (SD = 2.23)

1.80 (SD = 1.59)

*p < .05.

access to SEP services. There are a few potential explanations for these findings. For example, PWID who are
in periods of non-active substance use may have decreased motivation to travel to access non-injectionrelated services compared to when they were actively
injecting. This explanation may be particularly valid if
the main motivation for traveling to the SEP site was to
obtain sterile injection equipment rather than other services. Another potential explanation is that non-active
PWID may be seeking health care services elsewhere rather than going to the SEP site. We believe this explanation to be less valid given that, for many in this
population, the mobile SEP unit is the only source of
care that individuals have and/or trust. Harm reduction
providers should consider these issues when selecting
exchange sites.
Optimizing SEP access may increase retention and
utilization of syringe exchange services among active
PWID and increase access to social and health services
that may help sustain substance use cessation, such as
housing and other support services, for PWID who are
not active injectors. Challenges in optimizing SEP service delivery are exacerbated by policies that restrict
where SEP service provision may legally occur, such as
those that prohibit SEP operations within certain proximities to schools [14]. Future work should explore how
to enhance SEP service delivery in areas of greatest need
while taking into account policy restrictions on service
delivery and the non-equivalent access of current and
former PWID to SEP services.
This study has a number of limitations that warrant
discussion. The geometric point distance estimation
method assumes that all persons who report a given
unit of analysis—in this case, a zip code—reside at a
geometric centroid point. This is an important limitation given that gentrification and changes in residential
and commercial zoning may lead to uneven housing
opportunities and population distributions within a

given zip code. Further, we assumed persons are commuting from their home residence to the exchange site.
It may be the case that PWID are coming to exchange
sites from other points of origin, such as the places
where they purchase or inject their drugs or work.
Other research has explored the distance between these
locations and SEPs [8], but none has explored this issue
among PWID who are not in periods of active substance use.
Another limitation of this study is that we measured
walking distance, which would provide an inaccurate estimate of travel distance if individuals were utilizing public or private means of transportation. While use of such
modes of transport are a possibility, basing the travel estimate on walking distance was reasonable because our
harm reduction partnering organizations in DC validated
the fact that most of their PWID clients walk to access
SEP services because they often cannot afford other
means of transit. We cannot say with complete certainty
that everyone in our sample walked to engage with the
SEP. However, by limiting the analyses to persons who
were recruited during the first phase of the study, we excluded persons who received services via delivery or secondary exchangers. Nonetheless, these walking distance
estimates do not take into account other access barriers,
such as time spent planning for and utilizing different
modes of public transportation.
An additional limitation of this study is that it does
not account for the range of factors that may influence
SEP access, such as socioeconomic status or neighborhood characteristics. These data were not collected in
the capture-recapture study because it was felt that the
additional survey measures needed to obtain these data
would pose undue burden on participants, thus making
them reluctant to engage in our research. Future work
should explore the range of factors that may influence
PWID’s access to SEP and how these factors interact to
affect consistent utilization of services.
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Despite these limitations, these results highlight the
important role of harm reduction organizations in meeting the needs of active and non-active PWID. Provision
of comprehensive services for former substance users is
important given this population’s vulnerability and their
complex medical and social health care needs (such as
housing and addiction treatment and support). Harm reduction providers are uniquely poised to address these
needs, and can do so in a manner that will meet clients
“where they are at” in their cycle of addiction and
recovery.
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